cediranib

Known as: 4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline, Quinazoline, 4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(1-pyrrolidinyl)propoxy)- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
BACKGROUND Olaparib is a poly(ADP-ribose) polymerase inhibitor and cediranib is an anti-angiogenic agent with activity against… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Antiangiogenic therapy has shown clear activity and improved survival benefit for certain tumor types. However, an incomplete… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2013
Highly Cited
2013
PURPOSE Alveolar soft part sarcoma (ASPS) is a rare, highly vascular tumor, for which no effective standard systemic treatment… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2013
Review
2013
For almost four decades, my work has focused on one challenge: improving the delivery and efficacy of anticancer therapeutics… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE To compare the efficacy of cediranib (a vascular endothelial growth factor receptor tyrosine kinase inhibitor [VEGFR TKI… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Recurrent glioblastomas (rGBM) invariably relapse after initial response to anti-VEGF therapy. There are 2 prevailing hypotheses… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE Glioblastoma is an incurable solid tumor characterized by increased expression of vascular endothelial growth factor… (More)
  • table 1
  • table 3
  • table 2
  • table 4
  • table 5
Is this relevant?
Highly Cited
2010
Highly Cited
2010
To evaluate the role of apparent diffusion coefficient (ADC) imaging in assessing tumor cell infiltration after treatment with… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Early imaging or blood biomarkers of tumor response are desperately needed to customize antiangiogenic therapy for cancer… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE Recent clinical trials of antivascular endothelial growth factor (VEGF) agents for glioblastoma showed promising… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?